- A New Frontier for Convergence in Gastroenterology and Hepatology
Nov. 28(Thu) |
Unveiling the road to early diagnosis of panceatic cancer | Convention Hall C (4F) |
Chair(s) | Dong Ki Lee (Korea), Tooru Shimosegawa (Japan) | |
08:45-09:10 | Genetic evolution from PanIN to pancreatic cancer | Kee-Taek Jang (Korea) |
09:10-09:35 | Challenge to screen early pancreatic cancer in general population | Keiji Hanada (Japan) |
09:35-10:05 | Genetic predisposition to pancreatic cancer, results from genome-wide association studies (GWAS) | Laufey Amundadottir (USA) |
10:05-10:30 | How to diagnose early pancreatic cancer: from Japanese experiences | Tooru Shimosegawa (Japan) |
Nov. 28(Thu) 11:00-12:30 |
Current status and perspective for early diagnosis of pancreatic cancer | Convention Hall C (4F) |
Chair(s) | Laufey Amundadottir (USA), Yong-Tae Kim (Korea) | |
11:00-11:25 | Protein science; liquid-chromatography-tandem mass spectrometry : Mass spectrometry-based proteome profiling of extracellular vesicles and their roles in biology of Pancreatic ductal adenocarcinoma | Kwang Pyo Kim (Korea) |
11:25-11:45 | Circulating tumor DNA and cells for pancreatic cancer | Dong-Uk Kim (Korea) |
11:45-12:05 | Pancreatic cancer specific immunological marker: Paradigm shifting in combating with Pancreatic cancer | Dong Ki Lee (Korea) |
12:05-12:30 | Exosome in pancreatic cancer surveillance | Takahiro Ochiya (Korea) |
Nov. 28(Thu) 14:00-15:30 |
Development of novel targets for pancreatic cancer | Convention Hall C (4F) |
Chair(s) | Si Young Song (Korea), Hong-Sik Lee (Korea) | |
14:00-14:30 | Cancer meet Microbiome and Immunology | Hansoo Park (Korea) |
14:30-15:00 | Tumor microenvironment as a therapeutic target for pancreatic cancer | Volker Ellenrieder (Germany) |
15:00-15:30 | Drug development with genomic big data and artificial intelligence for pancreatic cancer | Si Young Song (Korea) |
Nov. 28(Thu) 16:00-17:30 |
New hope for treating pancreatic cancer | Convention Hall C (4F) |
Chair(s) | Volker Ellenrieder (Germany), Ho Soon Choi (Korea) | |
16:00-16:25 | Direct targeting oncogenic Ras mutants by IgG-format cytosol-penetrating antibody | Yong-Sung Kim (Korea) |
16:25-16:45 | Extracelluar vesicles (EVs): exosomes and microvesicles | Yong Song Gho (Korea) |
16:45-17:05 | Targeting altered metabolism in pancreatic cancer | Soo-Youl Kim (Korea) |
17:05-17:25 | Establishment of PDAC organoids model using EUS-guided tissue biopsy: a new window into understanding PDAC and drug discovery | Joo Kyung Park (Korea) |